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A 47-year-old African American male with end-
stage kidney disease (ESKD) on home hemodialysis
(HD), diabetes, hypertension, and type 2 pulmonary
hypertension with preserved ejection fraction was
referred for preoperative risk assessment to be listed for
kidney transplant. He was evaluated by a video visit
given the ongoing coronavirus disease 2019 (COVID-
19) viral pandemic by his primary care physician late
March 2020 and in 1st week of April 2020 by a cardi-
ologist. Review of primary care physician and
cardiologist notes highlighted patient had no general or
cardiac symptoms, was compliant with his medications
and performed his dialysis sessions regularly at home.
His medications included low dose aspirin, atorvastatin,
metoprolol, and insulin. He was felt to need further risk
assessment and subsequently underwent a same day rest-
regadenoson stress Technetium sestamibi SPECT/at-
tenuation correction CT study for preoperative risk
assessment on April 8th, 2020.
The study quality and perfusion/attenuation cor-
rection fusion data were all adequate and of good
quality. Review of the myocardial perfusion images
(Figures 1a and b) showed a mildly reversible anterior/
anterolateral perfusion defect less obvious after attenu-
ation correction with a summed difference score of 3
and the scan was read as mildly abnormal suggesting
mild ischemia but overall low ischemic burden risk.
Ejection fraction was 57% with no transient ischemic
dilation and no pharmacologic stress electrocardio-
graphic ischemia was noted.
Review of CT images done for attenuation correc-
tion (Figure 2) with bone window showed scattered 3
vessel coronary calcification. Lung window review of
CT showed peripheral bilateral ground glass opacities in
both lungs with a pattern suggestive of COVID-19
involvement.
Following the scan report, the primary care physi-
cian contacted the patient who again expressed no
symptoms. He was advised to get COVID-19 testing but
given that he was asymptomatic he couldn’t get it done
per hospital policy and had to be referred to free testing
sites offered at limited locations in Michigan regardless
of symptoms. He underwent a viral polymerase chain
reaction test for nCOV (COVID-19 RT PCR) which was
positive suggesting COVID-19 infection. He was
advised to quarantine from family for 2 weeks, updated
on COVID-19 symptoms to watch for and to seek
medical attention for any new symptoms. He has been
currently followed for over a month with no new
symptoms as of May 20th and feels well. His wife
worked at an outside hospital and was suspected to be
the source. She was notified and underwent testing and
found to be positive for COVID-19 and their children
were quarantined.
DISCUSSION
The world is currently under siege by the COVID-
19 pandemic and over the early months of 2020 the
myriad manifestations of this pandemic disease contin-
ues to unfold. We now know that this disease can be
asymptomatic in many and can be devastating with
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multisystem involvement leading to death in subset of
patients. Our case highlights what we believe is the first
reported case of bilateral pulmonary involvement of
COVID-19 (confirmed by swab testing for nCOV RNA)
identified on a routine outpatient cardiac SPECT CT
scan in an ESKD patient of home HD. Of note, the
patient was asymptomatic at the time of testing and
remains asymptomatic to this date despite pulmonary
findings of COVID-19.
It is well established that systematic review of CT
portion of myocardial perfusion SPECT CT is needed
given the substantial frequency of incidental non-cardiac
findings some of which may be of clinical significance
and prognostic impact.1 Chest CT is now identified as a
key to early diagnosis of suspected COVID-19 infection.
Jin et al.2 drafted a rapid advice guideline for manage-
ment of COVID-19 and defined 5 stages of involvement
of this disease with CT. Stages included ultra-early,
early, rapid progression, consolidation, and dissipation
stages. The ultra-early stage formed 8.4% of the patient
population in their analysis (7/83 cases). Criteria for this
ultra-early stage included being asymptomatic, positive
nasopharyngeal swab of nCoV, within 1-2 weeks of
exposure (history of contact with a patient or carrier or
medical staff in a cluster environment). CT findings for
this stage could include any of following: single, double,
or patchy ground glass opacities, peripheral location, air
bronchograms, nodules in central lobule surrounded by
patchy ground glass opacities, or patch consolidation.
We believe our patient on HD fitted into the category of
ultra-early stage as defined by them.
Bernheim et al on the other hand reported CT
findings and its relationship to duration of COVID-19
infection in symptomatic patients and reported 56% of
patients in early phase (1-2 days) of symptoms having
normal CT scan.3 Thus, COVID-19 appears to have both
early CT imaging findings in absence of symptoms as in
our patient and normal CT in presence of early symp-
toms which poses challenges in diagnosis based on
published studies.2,3
Patients with ESKD on HD have numerous co-
morbidities (diabetes and hypertension) and are clearly
at higher risk for COVID-19. The exact prevalence of
COVID-19 in HD patients is unknown and data from
China suggest large variations from different centers. In
one study of 201 HD patients, 5 were diagnosed with
COVID-19 (2.5%) and all 5 were symptomatic with CT
findings.4 A more important study5 showed that HD
patients were less likely to have symptoms with
COVID-19 compared to general population with 21%
of patients being completely asymptomatic. Adopting a
universal chest CT screening for hemodialysis patients
was felt to be the approach given lack of symptoms in
HD patients in this study. The exact reason why HD
patients are less symptomatic is unclear but early data
from China suggest this could be due to inherent
Figure 2. AC CT in lung window showing scattered bilateral peripheral located ground glass
opacities suggestive of COVID-19 infection. Subsequent nCOV PCR test was positive for viral
RNA.
bFigure 1. Non attenuated (top image) and attenuation cor-
rected (bottom image) SPECT perfusion images showing mild
reversible anterior anterolateral perfusion defect with summed
difference score of 3.
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immunosuppressed stage and inability to mount an
adequate cytokine response which has been blamed for
the progression of COVID-19.6
Of note our patient was on home HD and thus did
not even have the risk of being exposed to a cluster of
HD patients at the dialysis facility and did not come in
contact with a HD medical provider within past month
before testing per his history. The patient’s wife who is
his other family member working at a hospital facility
was the source of infection and she remains asymp-
tomatic to this date.
How is this case relevant to clinicians interpreting
cardiac SPECT CT scans and to nuclear labs in general?
At our institution, a COVID-19 directed symptom check
questionnaire has been implemented for the past 2 and
half months at time of scheduling any diagnostic non-
invasive test and is repeated 24 hours prior to the test
date at time of instructions. This is followed by repeat
symptom check after patient arrival on day of test along
with temperature screening and mandatory face mask
worn by patient for pharmacologic stress testing or any
other non-invasive procedures. All hospital personnel
are mandated to wear surgical face mask and diagnostic
testing personnel should wear gloves too. As a matter of
fact, a few medical diagnostic facilities and hospitals
around the US have implemented routine pre-procedural
PCR swab testing for COVID-19 1-2 days prior to any
diagnostic testing. Thus, it is unlikely that with these
measures we will miss the obvious symptomatic patient
prior to diagnostic testing and so can avoid bringing
them in for testing.
Our case differs from above scenarios and high-
lights the true challenge with COVID-19 diagnosis. The
asymptomatic infected patient with COVID-19. Cur-
rently as routine testing for asymptomatic patients is not
done in the US, the only way to avoid spread is to
practice universal hand hygiene, social distancing, and
wearing cloth/surgical face masks in public. From a
diagnostic standpoint, cardiologists and nuclear medi-
cine physicians reading cardiac SPECT CT should be
aware that the pulmonary manifestations of COVID-19
can be seen in lungs in ultra-early asymptomatic patient
too. These patients can easily make it to the nuclear lab
bypassing all initial checks given they pass all checks
like in our case and that most facilities like ours are not
routinely doing pre-procedural COVID-19 PCR testing
unless it is an aerosolizing procedural risk. This has
implications for nuclear stress testing lab personnel,
nuclear technologists, other hospital contacts in waiting
rooms, patient family members quarantine restrictions.
This case also highlights the growing importance of
cardiologists familiarity with interpretation of extra-
cardiac findings on SPECT CT. If unfamiliar or unsure
about findings, it is important to collaborate with
radiology to get the CT portion read with appropriate
lung windows and incorporate those findings into the
final SPECT report. It is not sufficient to just look at
coronary calcification as part of SPECT CT as the field
of view of gamma camera SPECT CT encompasses
lungs, pleura mediastinum, breast, ribs, and spine.
Cardiologists should continue to strive to build experi-
ence and knowledge in interpretation of non-cardiac
findings and instill importance of this to our trainees too.
In conclusion, COVID-19 continues to humble the
medical profession by its dramatic variations in clinical
presentation and this case highlights it can lurk in
shadows of a cardiac SPECT CT scan without any prior
warnings and warrants thorough review of the SPECT
CT scan.
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